advertisement

Topcon

Hu X 14

Showing records 1 to 14 | Display all abstracts from Hu X

104714 Hub Gene Screening Associated with Early Glaucoma: An Integrated Bioinformatics Analysis
Tian R
Computational and mathematical methods in medicine 2022; 2022: 8030243
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Hu X; Zhang B
Eye 2023; 37: 607-617
104714 Hub Gene Screening Associated with Early Glaucoma: An Integrated Bioinformatics Analysis
Li F
Computational and mathematical methods in medicine 2022; 2022: 8030243
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Li X
Eye 2023; 37: 607-617
104714 Hub Gene Screening Associated with Early Glaucoma: An Integrated Bioinformatics Analysis
Che S; Song M
Computational and mathematical methods in medicine 2022; 2022: 8030243
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Li M
Eye 2023; 37: 607-617
104714 Hub Gene Screening Associated with Early Glaucoma: An Integrated Bioinformatics Analysis
Liu L
Computational and mathematical methods in medicine 2022; 2022: 8030243
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Wang Y; Dan H
Eye 2023; 37: 607-617
104714 Hub Gene Screening Associated with Early Glaucoma: An Integrated Bioinformatics Analysis
Guo R; Li Z
Computational and mathematical methods in medicine 2022; 2022: 8030243
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Zhou J
Eye 2023; 37: 607-617
104714 Hub Gene Screening Associated with Early Glaucoma: An Integrated Bioinformatics Analysis
Hu X
Computational and mathematical methods in medicine 2022; 2022: 8030243
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Wei Y
Eye 2023; 37: 607-617
104714 Hub Gene Screening Associated with Early Glaucoma: An Integrated Bioinformatics Analysis
Zhang H
Computational and mathematical methods in medicine 2022; 2022: 8030243
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Ge K; Li P; Song Z
Eye 2023; 37: 607-617

Issue 23-2

Change Issue


advertisement

Oculus